The table below shows Pharma Penny Stocks Under Rs 100 based on the Highest Market Capitalization.
| Name | Market Cap (₹ Cr) | Close Price (₹) |
| Morepen Laboratories Ltd | 4,326.64 | 78.96 |
| Syncom Formulations (India) Ltd | 1,890.34 | 20.11 |
| Nectar Lifesciences Ltd | 752.4 | 33.55 |
| IND Swift Laboratories Ltd | 559.32 | 94.66 |
| Ambalal Sarabhai Enterprises Ltd | 438.04 | 57.16 |
| Gennex Laboratories Ltd | 427.83 | 18.81 |
| Medico Remedies Ltd | 409.19 | 49.31 |
| Shukra Pharmaceuticals Ltd | 268.11 | 61.23 |
| Pharmaids Pharmaceuticals Ltd | 239.01 | 67.77 |
| Kimia Biosciences Ltd | 224.07 | 46.5 |
Table of Contents
What Are Pharma Penny Stocks?
Pharma penny stocks in the Indian stock market are shares of small pharmaceutical companies priced below Rs 100. These stocks are highly speculative and involve significant risk due to their low market capitalization and potential for high volatility.
Investing in these stocks can be enticing due to the potential for substantial returns if a company succeeds in breakthrough developments or regulatory approvals. However, the risk of losing the entire investment is also considerably higher compared to more stable stocks.
Investors interested in pharma penny stocks should perform extensive due diligence, focusing on the company’s drug pipeline, market potential, and financial health. Understanding regulatory environments and market dynamics within India is crucial for assessing these investments.
Top 10 Pharma Penny Stocks Under Rs 100
The table below shows the Top 10 Pharma Penny Stocks Under Rs 100 based on 1 Year Return.
| Name | Close Price (₹) | 1-Year Return (%) |
| Shukra Pharmaceuticals Ltd | 61.23 | 169.04 |
| Murae Organisor Ltd | 2.41 | 138.61 |
| Pharmaids Pharmaceuticals Ltd | 67.77 | 79.52 |
| Ajooni Biotech Ltd | 7.57 | 74.53 |
| Syncom Formulations (India) Ltd | 20.11 | 68.92 |
| Morepen Laboratories Ltd | 78.96 | 65.99 |
| Ambalal Sarabhai Enterprises Ltd | 57.16 | 32.62 |
| Aarey Drugs and Pharmaceuticals Ltd | 59.74 | 22.59 |
| Kimia Biosciences Ltd | 46.5 | 22.37 |
| Gennex Laboratories Ltd | 18.81 | 21.07 |
Pharma Penny Stocks Under Rs 100 In India
The table below shows Pharma Penny Stocks Under Rs 100 In India based on 1 Month Return.
| Name | Close Price (₹) | 1-Month Return (%) |
| Pharmaids Pharmaceuticals Ltd | 67.77 | 111.35 |
| Murae Organisor Ltd | 2.41 | 94.62 |
| Ambalal Sarabhai Enterprises Ltd | 57.16 | 8.01 |
| Ajooni Biotech Ltd | 7.57 | 4 |
| Syncom Formulations (India) Ltd | 20.11 | 2.68 |
| Nectar Lifesciences Ltd | 33.55 | 2.13 |
| Syschem (India) Ltd | 39.94 | 1.37 |
| Kimia Biosciences Ltd | 46.5 | 0.66 |
| Lasa Supergenerics Ltd | 24.61 | 0.53 |
| Morepen Laboratories Ltd | 78.96 | 0.32 |
Best Pharma Penny Stocks Under Rs 100
The table below shows the Best Pharma Penny Stocks Under Rs 100 based on the highest day Volume.
| Name | Close Price (₹) | Daily Volume (Shares) |
| Morepen Laboratories Ltd | 78.96 | 7395159 |
| Nectar Lifesciences Ltd | 33.55 | 1668799 |
| Syncom Formulations (India) Ltd | 20.11 | 1402082 |
| Medico Remedies Ltd | 49.31 | 801134 |
| Murae Organisor Ltd | 2.41 | 420055 |
| Gennex Laboratories Ltd | 18.81 | 357400 |
| Ajooni Biotech Ltd | 7.57 | 343635 |
| Remedium Lifecare Ltd | 5.49 | 330622 |
| IND Swift Laboratories Ltd | 94.66 | 229468 |
| Vaishali Pharma Ltd | 16.26 | 209746 |
List Of Best Pharma Penny Stocks Under Rs. 100
The table below shows a List Of The Best Pharma Penny Stocks Under Rs. 100 based on PE Ratio.
| Name | Close Price (₹) | PE Ratio |
| IND Swift Laboratories Ltd | 94.66 | 1.43 |
| Remedium Lifecare Ltd | 5.49 | 11.77 |
| Shukra Pharmaceuticals Ltd | 61.23 | 18.88 |
| Gennex Laboratories Ltd | 18.81 | 28.68 |
| Aarey Drugs and Pharmaceuticals Ltd | 59.74 | 28.95 |
| Morepen Laboratories Ltd | 78.96 | 32.44 |
| Ambalal Sarabhai Enterprises Ltd | 57.16 | 51.03 |
| Medico Remedies Ltd | 49.31 | 51.71 |
| Syncom Formulations (India) Ltd | 20.11 | 57 |
| Nectar Lifesciences Ltd | 33.55 | 71.33 |
Who Should Invest In Pharma Penny Stocks Under Rs 100?
Investors who should consider pharma penny stocks under Rs 100 are those with high-risk tolerance, speculative investment strategies, and a thorough understanding of the pharmaceutical industry. Such investors must be prepared for significant volatility and the potential for both high returns and substantial losses.
How To Invest In The Pharma Penny Stocks Under Rs 100?
To invest in pharma penny stocks under Rs 100, research and select potential companies with promising pipelines or technologies. Use a reliable broker to buy shares, diversify your portfolio to mitigate risk, and stay updated on pharmaceutical industry news and regulatory changes affecting these stocks.
Performance Metrics Of Pharma Penny Stocks Under Rs 100
The performance metrics of pharma penny stocks under Rs 100 can be highly volatile, reflecting the speculative nature of these investments. Key indicators include share price fluctuations, trading volume, and financial health metrics such as earnings per share and revenue growth.
Investors should also consider the success rates of clinical trials, FDA approvals, and partnership developments as performance indicators. These metrics provide insights into a company’s potential to succeed in the competitive pharmaceutical market, impacting stock performance significantly.
Benefits Of Investing In Pharma Penny Stocks Under Rs 100
The main benefit of investing in pharma penny stocks under Rs 100 is the potential for high returns. These stocks often represent small companies that can experience significant growth if they achieve breakthroughs or gain regulatory approvals.
- High Return Potential: Pharma penny stocks can yield substantial profits if the company successfully brings a new drug to market or partners with larger pharmaceutical firms. Such events can dramatically increase a stock’s value overnight.
- Low Entry Cost: With shares priced under Rs 100, these stocks allow investors to buy a larger quantity of shares with a smaller initial investment, potentially maximizing gains if the stock value increases.
- Market Movements: These stocks are sensitive to market news and regulatory events, offering opportunities for quick gains from market reactions to positive news such as successful drug trials or government approvals.
- Diversification: Adding pharma penny stocks to a diversified investment portfolio can provide a balance to more stable investments. It introduces a higher-risk, higher-reward component that could yield returns uncorrelated with the broader market.
- Innovative Exposure: Investing in these stocks offers exposure to innovative medical research and potential breakthrough treatments that could revolutionize health care and generate significant financial returns if successful.
Challenges Of Investing In Pharma Penny Stocks Under Rs 100
The main challenges of investing in pharma penny stocks under Rs 100 include high volatility, limited liquidity, and significant regulatory risks. Additionally, these stocks often suffer from a lack of information and a higher potential for fraud, making them risky investments.
- High Volatility: Pharma penny stocks under Rs 100 are extremely volatile. Their prices can swing wildly based on news or market sentiment, making them unpredictable and increasing the risk of substantial losses for investors not prepared for such fluctuations.
- Limited Liquidity: These stocks often have lower trading volumes, which can make it difficult to buy or sell large quantities without affecting the stock price. This lack of liquidity can be a significant barrier when trying to exit positions at favorable prices.
- Regulatory Risks: The pharmaceutical industry is heavily regulated. Delays in drug approval processes or negative results from clinical trials can severely impact the stock’s value. Investors must be mindful of the regulatory environment and its potential effects.
- Lack of Information: Small pharmaceutical companies under Rs 100 often lack the visibility of larger companies. This scarcity of information can make it challenging for investors to perform thorough due diligence, assess the company’s potential, and make informed investment decisions.
- Fraud and Mismanagement Risk: The lower levels of scrutiny and oversight in smaller, less-regulated companies can lead to higher risks of fraud or mismanagement. Investors may face challenges in verifying the authenticity of the company’s claims and the integrity of its management.
Introduction To Pharma Penny Stocks Under Rs 100
Pharma Penny Stocks Under Rs 100 – Highest Market Capitalization
Morepen Laboratories Ltd
The Market Cap of Morepen Laboratories Ltd is ₹4,326.64 crore. The stock’s monthly return is 0.32%, and its one-year return is 65.99%. The stock is currently 27.79% away from its 52-week high.
Morepen Laboratories Ltd is a leading pharmaceutical company specializing in APIs, formulations, diagnostics, and over-the-counter (OTC) products. Established in 1984, the company serves global markets with a robust portfolio of health products and APIs. Its flagship brand, Dr. Morepen, has earned significant consumer trust.
Morepen focuses on innovation in the health sector with state-of-the-art facilities and cutting-edge research. The company’s global reach and strong market position make it a trusted name in the pharmaceutical and healthcare industries.
Syncom Formulations (India) Ltd
The Market Cap of Syncom Formulations (India) Ltd is ₹1,890.34 crore. The stock’s monthly return is 2.68%, and its one-year return is 68.92%. The stock is currently 38.74% away from its 52-week high.
Syncom Formulations (India) Ltd manufactures a wide range of pharmaceutical products, including tablets, capsules, liquids, and powders. With decades of expertise, the company caters to the domestic and export markets with affordable and quality formulations.
Committed to quality and innovation, Syncom Formulations is ISO-certified and operates with advanced facilities to meet global standards. It emphasizes customer-centric solutions and affordability, making it a significant player in the healthcare sector.
Nectar Lifesciences Ltd
The Market Cap of Nectar Lifesciences Ltd is ₹752.4 crore. The stock’s monthly return is 2.13%, and its one-year return is 10.21%. The stock is currently 68.41% away from its 52-week high.
Nectar Lifesciences Ltd is a fully integrated pharmaceutical company focusing on APIs and finished dosage forms. It operates in over 70 countries, offering high-quality, affordable medicines in critical therapeutic categories such as antibiotics and cardiovascular drugs.
With advanced manufacturing facilities and a strong emphasis on research, Nectar Lifesciences delivers exceptional value in healthcare. The company’s customer-centric approach ensures sustained growth and a significant presence in both domestic and global markets.
Top 10 Pharma Penny Stocks Under Rs 100 – 1 Year Return
Shukra Pharmaceuticals Ltd
The Market Cap of Shukra Pharmaceuticals Ltd is ₹268.11 crore. The stock’s monthly return is -8.68%, and its one-year return is 169.04%. The stock is currently 112.15% away from its 52-week high.
Shukra Pharmaceuticals Ltd manufactures a wide array of pharmaceutical products, including tablets, syrups, and injectables. The company focuses on catering to domestic and international clients with high-quality and cost-effective solutions.
Shukra is dedicated to expanding its footprint through innovative product development and advanced manufacturing facilities. Its ability to adapt to market demands has earned it a respected position in the pharmaceutical industry.
Murae Organisor Ltd
The Market Cap of Murae Organisor Ltd is ₹168 crore. The stock’s monthly return is 94.62%, and its one-year return is 138.61%. The stock is currently 28.63% away from its 52-week high.
Murae Organisor Ltd is engaged in providing healthcare-related products and services, with a focus on operational excellence. Its diversified offerings cater to evolving market demands across the pharmaceutical and healthcare sectors.
The company’s strategic approach and commitment to innovation make it a key player in the healthcare industry. It continues to drive growth with customer-centric solutions.
Pharmaids Pharmaceuticals Ltd
The Market Cap of Pharmaids Pharmaceuticals Ltd is ₹239.01 crore. The stock’s monthly return is 111.35%, and its one-year return is 79.52%. The stock is currently 29.05% away from its 52-week high.
Pharmaids Pharmaceuticals Ltd manufactures APIs and finished pharmaceutical products for both the domestic and international markets. Its wide product portfolio focuses on affordability and accessibility to cater to a growing healthcare demand.
With an emphasis on R&D and quality, Pharmaids Pharmaceuticals ensures its products meet global standards. The company’s strategic vision is driving its growth across various healthcare segments.
Pharma Penny Stocks Under Rs 100 In India – 1 Month Return
Ambalal Sarabhai Enterprises Ltd
The Market Cap of Ambalal Sarabhai Enterprises Ltd is ₹438.04 crore. The stock’s monthly return is 8.01%, and its one-year return is 32.62%. The stock is currently 35.93% away from its 52-week high.
Ambalal Sarabhai Enterprises Ltd is a renowned pharmaceutical and industrial conglomerate known for its contributions to healthcare and technology. The company offers a diverse range of pharmaceutical products and services, emphasizing innovation and quality to meet global healthcare needs.
Founded with a legacy of excellence, Ambalal Sarabhai Enterprises Ltd has a rich history of pioneering advancements in pharmaceuticals and industrial chemicals. Over the years, it has established itself as a trusted name, driving progress in healthcare and industrial solutions.
Ajooni Biotech Ltd
The Market Cap of Ajooni Biotech Ltd is ₹130.39 crore. The stock’s monthly return is 4%, and its one-year return is 74.53%. The stock is currently 36.59% away from its 52-week high.
Ajooni Biotech Ltd is an innovative biotechnology company focused on manufacturing and supplying high-quality animal healthcare products. The company specializes in providing nutritional and medicinal solutions, catering to the livestock and poultry industries with a commitment to sustainability and excellence.
Since its establishment, Ajooni Biotech Ltd has played a pivotal role in improving animal health and productivity. With a strong emphasis on research and development, the company continuously enhances its product range to meet evolving industry demands and standards.
Syschem (India) Ltd
The Market Cap of Syschem (India) Ltd is ₹159.21 crore. The stock’s monthly return is 1.37%, and its one-year return is -21.64%. The stock is currently 85.03% away from its 52-week high.
Syschem (India) Ltd is a prominent name in the pharmaceutical sector, specializing in manufacturing high-quality bulk drugs and intermediates. The company is committed to ensuring excellence in production, adhering to stringent industry standards, and meeting global healthcare needs.
Established with a vision to innovate in the pharmaceutical domain, Syschem (India) Ltd has steadily expanded its capabilities over the years. Its focus on research and development and sustainable practices has positioned it as a trusted partner in the healthcare industry.
Best Pharma Penny Stocks Under Rs 100 – Highest Day Volume
Medico Remedies Ltd
The Market Cap of Medico Remedies Ltd is ₹409.19 crore. The stock’s monthly return is -12.27%, and its one-year return is -38.82%. The stock is currently 88.5% away from its 52-week high.
Medico Remedies Ltd manufactures formulations and generics, serving both domestic and international markets. The company specializes in high-quality medicines, catering to therapeutic segments like cardiovascular and anti-infectives.
Medico Remedies is committed to expanding its market presence through innovation and partnerships. Its focus on delivering quality healthcare solutions aligns with its vision for long-term growth.
Gennex Laboratories Ltd
The Market Cap of Gennex Laboratories Ltd is ₹427.83 crore. The stock’s monthly return is -5.66%, and its one-year return is 21.07%. The stock is currently 54.17% away from its 52-week high.
Gennex Laboratories Ltd is a leading pharmaceutical company specializing in manufacturing Active Pharmaceutical Ingredients (APIs) and intermediates. Known for its quality and innovation, the company serves a diverse range of industries, including healthcare, biotechnology, and veterinary medicine.
Since its inception, Gennex Laboratories Ltd has built a strong reputation for adhering to global regulatory standards. With a focus on research and development, the company continuously advances its processes to deliver sustainable and effective solutions to its customers worldwide.
Remedium Lifecare Ltd
The Market Cap of Remedium Lifecare Ltd is ₹221.36 crore. The stock’s monthly return is -5.72%, and its one-year return is -74.78%. The stock is currently 596.72% away from its 52-week high.
Remedium Lifecare Ltd is a dynamic pharmaceutical company focused on providing a wide range of healthcare solutions. The company specializes in manufacturing and distributing medicines across diverse therapeutic areas, ensuring accessibility and quality for patients worldwide.
With a commitment to innovation, Remedium Lifecare Ltd has steadily expanded its footprint in the pharmaceutical industry. Since its establishment, the company has emphasized research and development, driving advancements in drug formulation and fostering partnerships to improve global healthcare outcomes.
List Of Best Pharma Penny Stocks Under Rs. 100 – PE Ratio
Ind Swift Ltd
The Market Cap of IND Swift Laboratories Ltd is ₹559.32 crore. The stock’s monthly return is -19.51%, and its one-year return is 0.44%. The stock is currently 96.49% away from its 52-week high.
Ind Swift Ltd is a pharmaceutical company specializing in APIs and formulations. With a strong focus on R&D and manufacturing, the company serves both domestic and global markets with high-quality products.
The company’s commitment to innovation and operational efficiency has strengthened its position in the healthcare sector. Ind Swift’s extensive product portfolio caters to various therapeutic areas, making it a trusted brand.
Aarey Drugs and Pharmaceuticals Ltd
The Market Cap of Aarey Drugs and Pharmaceuticals Ltd is ₹169.99 crore. The stock’s monthly return is -1.09%, and its one-year return is 22.59%. The stock is currently 25.21% away from its 52-week high.
Aarey Drugs and Pharmaceuticals Ltd is a well-established company in the pharmaceutical industry, specializing in the production of bulk drugs and intermediates. The company is dedicated to delivering high-quality products that meet stringent global healthcare standards.
Since its inception, Aarey Drugs has built a reputation for innovation and reliability in the pharmaceutical supply chain. With a focus on research and development, the company continuously enhances its manufacturing processes to cater to evolving industry demands and therapeutic needs.
Vaishali Pharma Ltd
The Market Cap of Vaishali Pharma Ltd is ₹212.13 crore. The stock’s monthly return is -9.36%, and its one-year return is 15.65%. The stock is currently 53.2% away from its 52-week high.
Vaishali Pharma Ltd is a prominent player in the pharmaceutical sector, specializing in manufacturing, exporting, and distributing a wide range of healthcare products. The company is committed to offering quality medicines, focusing on ethical healthcare solutions and innovation.
Founded with the vision of improving global healthcare accessibility, Vaishali Pharma Ltd has established a strong presence across domestic and international markets. With a diversified portfolio, it caters to various therapeutic segments, emphasizing excellence in production and distribution.
Top 10 Pharma Penny Stocks Under Rs 100- FAQs
Best Pharma Penny Stocks Under Rs 100 # 1: Morepen Laboratories Ltd
Best Pharma Penny Stocks Under Rs 100 # 2: Syncom Formulations (India) Ltd
Best Pharma Penny Stocks Under Rs 100 # 3: Nectar Lifesciences Ltd
Best Pharma Penny Stocks Under Rs 100 # 4: IND Swift Laboratories Ltd
Best Pharma Penny Stocks Under Rs 100 # 5: Ambalal Sarabhai Enterprises Ltd
The Best Pharma Penny Stocks Under Rs 100 are based on market capitalization.
Based on the one-year return, Shukra Pharmaceuticals Ltd, Murae Organisor Ltd, Pharmaids Pharmaceuticals Ltd, Ajooni Biotech Ltd, and Syncom Formulations (India) Ltd.
Yes, you can invest in pharma penny stocks under Rs 100, but it involves high risk. Thorough research and a clear understanding of the risks associated with such speculative investments are essential.
Investing in pharma penny stocks under Rs 100 can be profitable but is highly risky. It suits investors who are comfortable with potential high volatility and the possibility of significant financial losses.
To invest in pharma penny stocks under Rs 100, research thoroughly, choose a reputable brokerage, monitor the pharmaceutical industry closely, and diversify your investments to mitigate risks.
Here are some of the Best Stock Research Articles listed based on Top Sectors (Industries), Market Cap, and Fundamental Analysis Factors:
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.
